Literature DB >> 11718050

[The epidemiology of irritable bowel syndrome and functional constipation of Guangzhou residents].

X Wei1, M Chen, J Wang.   

Abstract

OBJECTIVE: To investigate the prevalence rates of irritable bowel syndrome (IBS) and functional constipation in Guangzhou City.
METHODS: A structured history using a questionnaire on gastrointestinal symptoms during the preceding one year was obtained from random sampling 2,892 residents, 1,006 consecutively patients who visited general practitioner and 495 consecutively patients who visited gastroenterologists. All the questionnaires were filled by trained doctors.
RESULTS: The overall prevalence rates of irritable bowel syndrome and functional constipation in Guangzhou City were 5.6% and 3.0%. There were 10.1%, 34.3% and 5.4%, 4.8% visitors who complained IBS and functional constipation in the general internal outpatient department and gastrointestinal outpatient department. The female was predominant in both IBS and functional constipation. The ratio of male to female was 1:1.51 and 1:1.77. With the increase of age, the prevalence rate of functional constipation rose; but IBS did not. There were 23.9% IBS patients and 17.6% functional constipation patients who had ever seen a doctor for these diseases in the community. The percentages of IBS subclasses were as the following: diarrhea predominant: 63.2%; constipation predominant: 27.0%; others: 9.8%.
CONCLUSION: The prevalence rates of IBS and functional constipation in Guangzhou City were lower than that in west countries.

Entities:  

Mesh:

Year:  2001        PMID: 11718050

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  11 in total

1.  The therapeutic effect of Xiaopi-I on functional dyspepsia.

Authors:  Hui Li; Zhen-Yu Yang; Yan Li
Journal:  Chin J Integr Med       Date:  2012-02-27       Impact factor: 1.978

2.  Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran.

Authors:  Delnaz Roshandel; Mohammadreza Rezailashkajani; Sepideh Shafaee; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2006-03-25       Impact factor: 2.571

3.  Five-year follow-up of 263 cases of functional bowel disorder.

Authors:  Yu-Rong Tang; Ping Wang; Rui Yin; Jian-Xin Ge; Guo-Pin Wang; Lin Lin
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

4.  Body awareness therapy: a new strategy for relief of symptoms in irritable bowel syndrome patients.

Authors:  E M Eriksson; I E Möller; R H Söderberg; H T Eriksson; G K Kurlberg
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

5.  Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers.

Authors:  Elsa M Eriksson; Kristina I Andrén; Henry T Eriksson; Göran K Kurlberg
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

6.  Functional bowel disorders in Iranian population using Rome III criteria.

Authors:  Majid Sorouri; Mohammad A Pourhoseingholi; Mohsen Vahedi; Azadeh Safaee; Bijan Moghimi-Dehkordi; Asma Pourhoseingholi; Manijeh Habibi; Mohammad R Zali
Journal:  Saudi J Gastroenterol       Date:  2010 Jul-Sep       Impact factor: 2.485

7.  Effects of demographic factors, body mass index, alcohol drinking and smoking habits on irritable bowel syndrome: a case control study.

Authors:  N Farzaneh; M Ghobaklou; B Moghimi-Dehkordi; N Naderi; F Fadai
Journal:  Ann Med Health Sci Res       Date:  2013-07

Review 8.  Epidemiology characteristics of constipation for general population, pediatric population, and elderly population in china.

Authors:  Huikuan Chu; Likun Zhong; Hai Li; Xiujing Zhang; Jingzhi Zhang; Xiaohua Hou
Journal:  Gastroenterol Res Pract       Date:  2014-10-16       Impact factor: 2.260

9.  Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome.

Authors:  Lijun Mei; Jiaoli Zhou; Yimo Su; Kunhong Mao; Jing Wu; Caicai Zhu; Ling He; Ying Cui
Journal:  BMC Gastroenterol       Date:  2021-03-05       Impact factor: 3.067

10.  Efficacy and safety of acupuncture for functional constipation: a randomised, sham-controlled pilot trial.

Authors:  Hye-Yoon Lee; Oh-Jin Kwon; Jung-Eun Kim; Mikyeong Kim; Ae-Ran Kim; Hyo-Ju Park; Jung-Hyo Cho; Joo-Hee Kim; Sun-Mi Choi
Journal:  BMC Complement Altern Med       Date:  2018-06-15       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.